bpc-157 fibrosis risk Multifunctionality and Possible Medical Application of the BPC 157 Peptide—Literature and Patent Review Peptide Therapy for Inflammation: A
Description
BPC-157: nitric oxide, angiogenesis, tendon-fibroblast outgrowth BPC-157 (Body Protection Compound 157) is a 15-amino-acid pentadecapeptide first characterized by the Sikiric group at the University of Zagreb beginning in the early 1990s
doi: 10.1016/j.cell.2021.04.041
Risks include inconsistent production, inaccurate dosing, contamination, and impurities
C.RitchieK.BroichK.et al (2006)
A doctors involvement transforms a risky experiment into a structured, data-driven therapeutic strategy
&srotate=0)
